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height, body weight, smoking, alcohol drinking, systolic pressure
(SBP), diastolic pressure (DBP), fasting glucose (GLU), triglycerides
(TG), high-density lipoprotein cholesterol (HDL-C), total cholesterol
(TC), Hcy and past diseases history. After the stratiﬁcation of risk
factors, comparison of stroke morbidity in normal Hcy group and high
Hcy group respectively. Moreover, the correlation between the stroke
morbidity and the risk factors was analyzed using trend test. Hcy
values were log-transformed to normalize the distribution, with ter-
tile levels as follows: <1.09, 1.09-1.23 and >1.23. We further examined
the detectable interaction between Hcy and stratiﬁed factors on
predicting the risk of stroke by adding the Hcy  stratiﬁed factors
cross-product to a logistic regression analysis of the hypertension
participants.
RESULTS In HHcy group, hypertension patients with stroke had a
signiﬁcantly higher age, fasting GLU, SBP and DBP level than that of
patients without stroke, and diabetes mellitus was noted in 30.29%
of individuals with stroke compared to 13.72% without stroke. Gradual
elevation of stroke morbidity was identiﬁed with the increase of
fasting GLU, SBP and DBP, and the correlation rank of the three risk
factors and stroke morbidity was as follows: SBP (r ¼0.431, P <0.001)
>DBP (r ¼0.401, P <0.001) > GLU (r ¼0.123, P <0.001). In patients with
hypertension, an increasing level of Hcy was associated with higher
stroke risk in the following stratiﬁed factors, including age range (45-
74) years, BMI <28 kg/m2, DBP<110mmHg, TG <150 mg/dL, fasting
GLU range of <6.1 mmol/L and 7.0 mmol/L, and full scope of SBP and
non-HDL-C. In those with Log HCY > 1.23, SBP 180 mmHg group was
found to have the highest risk of stroke (OR 6.240, 95% CI 1.349 to
28.863) among the signiﬁcant independent risk factors. Among the
hypertension participants, signiﬁcant interaction on stroke risk was
observed between Hcy and blood pressure (both SBP and DBP) after
adjustment for age, sex, ethnicity, and the baseline values for the
respective outcome traits (both P for interaction <0.001).
CONCLUSIONS In conclusion, comprehensive evaluation and strict
management of multiple risk factors have become increasingly
important in the alleviation of stroke morbidity for hypertension
patients with HHcy since the cohort of patients were more sensitive
to the classic risk factors.
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OBJECTIVES To investigate the Hsf-1 expression within the ﬁrst 48
hours from onset in acute ischemic stroke (AIS) patients and its rela-
tionship with stroke subtype.
METHODS The expression of Hsf-1 mRNA in PBMCwas determined using
reverse transcription PCR (RT-PCR) from 62 AIS patients and 31 healthy
controls. Patientswereclassiﬁed intosubtypesaccording toTOASTcriteria.
AIS patientswere examinedwith National Institutes of Health Stroke Scale
(NIHSS) on admission and the modiﬁed Rankin scale score (mRS) at 3
months after admission. SPSS 13.0 was used for data analysis.
RESULTS There was no signiﬁcant difference between mild and se-
vere types(0.4600.153 vs 0.3990.158, P¼0.138). Further stratiﬁed
analysis was used, the mRNA expression of Hsf-1 in PBMC of LAA
group was evidently higher than that in SAA group (0.4790.171 vs
0.3540.109, P<0.001). Modiﬁed Rankin scale scores (mRS) at the
post-onset 3 month were positively correlated with the expression of
Hsf-1 at the post-onset 48 hours (P¼0.007).
CONCLUSIONS The changes of Hsf-1 level may reﬂect the etiological and
pathophysiological diversity of AIS. Hsf-1 might play a role in etiological
diagnosis of ischemic stroke subtype. The Hsf-1 level within 48 hours
after onset could indicate the prognosis in patients with AIS.
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Xuzhou, Jiangsu, P.R. ChinaOBJECTIVES Hyperhomocysteinemia (HHcy) was a well-known risk
factor for vascular disease, such as peripheral vascular disease, cere-
brovascular disease, hypertension, coronary artery disease and deep-
vein thrombosis. In this study, we sought to explore the effect of an
elevated plasma homocysteine (Hcy) concentration and conventional
predisposing factors on stroke incidence.
METHODS A total of 1460 patients with HHcy were enrolled in this
study, including 865 (52.74%) stroke cases. The clinical characteristics of
1460 HHcy patients were collected, including age, sex, cigarette smoking,
alcohol consumption, blood pressure, blood lipids, fasting glucose, Hcy,
and other complicated diseases. Signiﬁcant independent risk factors for
stroke found through a conditional logistic modeling approach. Estimates
of relative risks for stroke in patients with HHcy were based on odds
ratios (ORs) with their associated 95% conﬁdence intervals (CIs) from
logistic regression. Trend analysis was used to perform the correlation
between Hcy status and the risk of stroke by spearman’s rho.
RESULTS HHCY patients with stroke had a signiﬁcantly higher systolic
pressure (SBP), diastolic pressure (DBP), fasting glucose (GLU) and Hcy
level than that of patients without stroke, as was also their exposure to
hypertension and diabetes mellitus (P<0.05). In binary logistic regression
analysis, hypertension (OR 1.967, 95% CI 1.429 to 2.709), diabetes mellitus
(OR 1.815, 95% CI 1.308 to 2.518), high SBP (OR 1.037, 95% CI 1.027 to
1.046) / DBP (OR 1.026, 95% CI 1.011 to 1.042), elevated Hcy (OR 1.016, 95%
CI 1.007 to 1.024), and decrease in high-density lipoprotein cholesterol
(OR 0.963, 95% CI 0.952 to 0.975) level emerged as independent pre-
dictors of stroke (P<0.05). An increasing level of Hcy was associated with
higher stroke risk due to elevated levels of fasting GLU (r ¼ 0.161,
P <0.001), SBP (r ¼ 0.529, P<0.001) and DBP (r ¼ 0.491, P <0.001) by the
risk factors stratiﬁcation. SBP was found to have the highest risk of stroke
among the signiﬁcant independent risk factors.
CONCLUSIONS Since many vascular risk factors (such as weight,
blood glucose, blood pressure and blood lipids) were potentially
modiﬁable, the magnitude of the effect on comprehensive interven-
tion of vascular factors could be growing recognition in the develop-
ment of stroke, rather than using only the level of one cardiovascular
disease risk factor. Hyperhomocysteinemia was an independent risk
factor for stroke. Given the prevention of stroke in patients with or
without stroke, a rigorous management of the elevated serum ho-
mocysteine levels should give our full attention.GW26-e4461
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OBJECTIVES The migration of transplanted neural progenitor cell
(NPC) or endogenesis NPC to damaged sections in the central nervous
system (CNS) is a critical step for NPC therapy. A combination of
extracellular signals and microenvironmental conditions is necessary
for the migration of NPC. Astrocytes, as the major nonneuronal cells in
the brain, can be activated by injuries to express chemoattractants
that can direct the migration of NPC.
METHODS Astrocytes cell and NPCs were cultured and identiﬁed
separately, then astrocyte was treated with Baicalin after being
exposed to hypoxia for 18h. Cell migration assays were performed
with Costar Transwell inserts.
RESULTS Astrocytes treated with 160 mg/ml baicalin and exposed to
hypoxia for18h at the same time. Migration assays with transwell
showed the conditioned medium of hypoxia and balcalin-induced
astrocytes increased the migration of NPCs compared to baicalin
absence. Real-time RT-PCR assay indicated that mRNA of VEGF and
MCP-1 has been upregulated by baicalin in astrocytes exposed to
hypoxia and block chemotaxis assay furthermore demonstrated that
the high expressions of VEGF and MCP-1 involved in the improvement
of the migration of NPCs.
CONCLUSIONS Data in this paper has ﬁrstly shown baicalin can in-
crease the chemotactic ability of astrocyte to NPC in vitro under
hypoxia condition via upregulation of VEGF and MCP-1 in astrocyte.
The results provide supports for exploring a clinical role for baicalin in
NPCs therapy.
